Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
|---|---|---|---|---|---|
| 1 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 2 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
VEGFA [2] VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 3 | Bladder cancer 💬 11 genes, 26 drugs (DrugBank) and 33 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 4 | Bladder cancer 💬 11 genes, 26 drugs (DrugBank) and 33 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 5 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 6 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
VEGFA [2] VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 7 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 8 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 9 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 10 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 11 | Collecting duct acid secretion 💬 3 genes, 10 drugs (DrugBank) and 36 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Lansoprazole Lansoprazole 💬
| Lansoprazole | 063 [8] 63, 71, 85, 98, 166, 222, 223, 299 💬
|
| 12 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 13 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 14 | Focal adhesion 💬 31 genes, 52 drugs (DrugBank) and 54 diseases |
PGF [3] PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 15 | Focal adhesion 💬 31 genes, 52 drugs (DrugBank) and 54 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 16 | Gastric acid secretion 💬 14 genes, 54 drugs (DrugBank) and 63 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Lansoprazole Lansoprazole 💬
| Lansoprazole | 063 [8] 63, 71, 85, 98, 166, 222, 223, 299 💬
|
| 17 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 18 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 19 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 20 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 21 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 22 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 23 | Integrin signaling 💬 28 genes, 48 drugs (DrugBank) and 77 diseases |
PGF [3] PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 24 | Integrin signaling 💬 28 genes, 48 drugs (DrugBank) and 77 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 25 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 26 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 27 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
PGF [3] PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 28 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 29 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 30 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 31 | Oxidative phosphorylation 💬 2 genes, 7 drugs (DrugBank) and 29 diseases |
ATP4A [2] ATP4A, ATP4B 💬
|
Lansoprazole Lansoprazole 💬
| Lansoprazole | 063 [8] 63, 71, 85, 98, 166, 222, 223, 299 💬
|
| 32 | Pancreatic cancer 💬 20 genes, 43 drugs (DrugBank) and 86 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 33 | Pancreatic cancer 💬 20 genes, 43 drugs (DrugBank) and 86 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 34 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
PGF [3] PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 35 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 36 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
PGF [3] PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 37 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 38 | Proteoglycans in cancer 💬 34 genes, 75 drugs (DrugBank) and 107 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 39 | Proteoglycans in cancer 💬 34 genes, 75 drugs (DrugBank) and 107 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 40 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
PGF [3] PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 41 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 42 | Ras signaling pathway 💬 38 genes, 65 drugs (DrugBank) and 77 diseases |
PGF [3] PGF, VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 43 | Ras signaling pathway 💬 38 genes, 65 drugs (DrugBank) and 77 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 44 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 45 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
VEGFA [2] VEGFA, VEGFB 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 46 | Renal cell carcinoma 💬 15 genes, 16 drugs (DrugBank) and 32 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 47 | Renal cell carcinoma 💬 15 genes, 16 drugs (DrugBank) and 32 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 48 | Rheumatoid arthritis 💬 39 genes, 59 drugs (DrugBank) and 85 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 49 | Rheumatoid arthritis 💬 39 genes, 59 drugs (DrugBank) and 85 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
| 50 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
VEGFA [1] VEGFA 💬
|
Aflibercept Aflibercept 💬
| Aflibercept | 090 [2] 90, 166 💬
|
| 51 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
VEGFA [1] VEGFA 💬
|
Ranibizumab Ranibizumab 💬
| Ranibizumab | 034 [4] 34, 166, 227, 301 💬
|
